LIMITED OFFER
Save 50% on book bundles
Immediately download your ebook while waiting for your print delivery. No promo code needed.
Clinical PET/CT: Quarter-Century Transformation of Oncology, An Issue of PET Clinics
- 1st Edition, Volume 19-2 - February 28, 2024
- Author: Rathan M. Subramaniam
- Language: English
- Hardback ISBN:9 7 8 - 0 - 4 4 3 - 1 3 0 6 9 - 4
- eBook ISBN:9 7 8 - 0 - 4 4 3 - 1 3 0 7 0 - 0
In this issue of PET Clinics, guest editor Dr. Rathan M. Subramaniam brings his considerable expertise to the topic of Clinical PET/CT: Quarter-Century Transformation of Oncology.… Read more
Purchase options
Institutional subscription on ScienceDirect
Request a sales quoteIn this issue of PET Clinics, guest editor Dr. Rathan M. Subramaniam brings his considerable expertise to the topic of Clinical PET/CT: Quarter-Century Transformation of Oncology. The first PET-CT prototype for clinical evaluation was installed at the University of Pittsburgh Medical Center in 1998, and combined PET/CT scanners perform almost all PET scans today. These combined scans help pinpoint abnormal metabolic activity and may provide more accurate diagnoses than the two scans performed separately. In this issue, top experts discuss specific cancers where PET/CT is used and how it has transformed diagnosis in that area.
- Contains 14 relevant, practice-oriented topics on PET/CT transformation of oncology, including breast cancer, hepatobiliary and pancreatic cancer, gastric and colonic cancers, multiple myeloma, prostate cancer, and more.
- Provides in-depth clinical reviews on how PET/CT has transformed oncology over the last 25 years, offering actionable insights for clinical practice.
- Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.
Nuclear medicine radiologists
- Cover image
- Title page
- Table of Contents
- Copyright
- Contributors
- Forthcoming Issues
- CME Accreditation Page
- Preface
- Quarter Century Positron Emission Tomography/Computed Tomography Transformation of Oncology: Head and Neck Cancer
- Key points
- Introduction
- Evidential clinical practice
- Nasopharyngeal cancer
- Future directions
- Clinics care points
- Positron Emission Tomography/Computed Tomography in Thyroid Cancer: An Updated Review
- Key points
- Introduction
- Others
- Summary
- Clinics care points
- Quarter-Century Transformation of Oncology: Positron Emission Tomography for Patients with Breast Cancer
- Key points
- Molecular classification of breast cancer
- 18F-fluorodeoxyglucose
- Sodium fluoride
- 16α-18F-fluoro-17β-fluoroestradiol
- Novel positron emission tomography radiotracers in clinical trials
- Technologic developments
- Summary
- Clinics care points
- Quarter-Century PET/Computed Tomography Transformation of Oncology: Hepatobiliary and Pancreatic Cancer
- Key points
- Introduction
- Hepatocellular carcinoma
- [18F] fluorodeoxyglucose PET/computed tomography
- Gallium-68-fibroblast activation protein inhibitor PET/computed tomography
- Biliary malignancy
- Cholangiocarcinoma
- [18F] fluorodeoxyglucose PET/computed tomography
- Gallbladder carcinoma
- Pancreatic cancer
- Summary
- Clinics care points
- Role of PET/Computed Tomography in Gastric and Colorectal Malignancies
- Key points
- Introduction
- 18F-FDG PET technique
- Gastric cancer
- Clinical indications of PET/computed tomography imaging
- Clinical indications of PET/computed tomography imaging
- Other radiopharmaceuticals and future directions
- Summary
- Clinics care points
- Quarter Century PET/Computed Tomography Transformation of Oncology: Neuroendocrine Tumors
- Key points
- Introduction
- Management of neuroendocrine tumors
- PET imaging of neuroendocrine tumors
- PET radiotracers for the evaluation of neuroendocrine tumors
- Somatostatin receptor PET/computed tomography imaging in the staging of neuroendocrine tumors
- Role of somatostatin receptor PET/computed tomography in treatment response assessment and restaging of neuroendocrine tumors
- Somatostatin receptor PET/MRI in the evaluation of neuroendocrine tumors
- Theranostics in the management of neuroendocrine tumors
- Summary
- Clinics care points
- PET/Computed Tomography Transformation of Oncology: Kidney and Urinary Tract Cancers
- Key points
- Introduction
- Role of 2-deoxy-2-[18F]fluoro-D-glucose PET in renal cell carcinoma
- Role of 2-deoxy-2-[18F]fluoro-D-glucose PET in urothelial carcinoma
- Imaging of cancer epithelial targets in renal cell and urothelial carcinomas
- Imaging of the tumor microenvironment in renal cell and urothelial carcinomas
- Comment and future perspectives
- Clinics care points
- PET/Computed Tomography Transformation of Oncology: Ovarian Cancers
- Key points
- Introduction
- Summary
- Clinics care points
- Positron Emission Tomography/Computed Tomography Transformation of Oncology: Musculoskeletal Cancers
- Key points
- Introduction
- Bone and soft tissue sarcomas
- PET/CT guidelines
- Diagnosis
- Staging and prognosis
- Treatment response and surveillance
- Future directions
- Summary
- Clinics care points
- Positron Emission Tomography/Computed Tomography Transformation of Oncology: Melanoma and Skin Malignancies
- Key points
- Background
- Staging systems for melanoma
- Treatments for local and regional melanoma
- Adjuvant therapy of malignant melanoma
- Treatment of metastatic malignant melanoma
- Investigations for primary melanoma
- Future directions
- Summary
- Clinics care points
- Positron Emission Tomography/Computed Tomography Transformation of Oncology: Multiple Myeloma
- Key points
- Introduction
- Initial diagnosis
- Initial staging
- 18F FDG PET/CT prognostic value
- Assessment of treatment response
- 18F FDG PET/CT and stem cell transplantation
- Minimal residual disease
- Monoclonal gammopathy of undetermined significance
- Smoldering myeloma
- Solitary plasmacytoma
- Novel imaging targets
- Summary
- Clinics care points
- Clinical Positron Emission Tomography/Computed Tomography: Quarter-Century Transformation of Prostate Cancer Molecular Imaging
- Introduction
- Before the era of prostate-specific membrane antigen
- Development of prostate-specific membrane antigen
- Prostate specific membrane antigen PET-guided treatments
- The next quarter-century in clinical PET/computed tomography for prostate cancer
- Summary
- Clinics care points
- Quarter-Century PET/CT Transformation of Oncology: Lymphoma
- Key points
- Introduction
- Classification of lymphoid neoplasms
- Historical overview
- Diagnosis and initial staging
- Therapy monitoring
- Summary and future directions
- Clinics care points
- PET/Computed Tomography Transformation of Oncology: Immunotherapy Assessment
- Key points
- Introduction
- Challenges in defining early response to immunotherapy on conventional imaging
- The case for metabolic imaging using FDG PET/CT
- Differentiating pseudoprogression from hyperprogression
- Dissociated response
- 18F-FDG PET/Computed Tomography prognostication
- 18F-FDG PET/computed tomoraphy, systemic immune response, and immunotherapy-related adverse events
- Novel PET tracers
- Summary
- Clinics care points
- No. of pages: 240
- Language: English
- Edition: 1
- Volume: 19-2
- Published: February 28, 2024
- Imprint: Elsevier
- Hardback ISBN: 9780443130694
- eBook ISBN: 9780443130700
RS
Rathan M. Subramaniam
Affiliations and expertise
Associate Professor of Radiology, Russell H Morgan Department of Radiology and Radiologic Sciences, John Hopkins Medical Institutions